Can a newer MR contrast agent be used to monitor disease progression in muscular dystrophy?
- PMID: 19092081
- DOI: 10.1148/radiol.2501081665
Can a newer MR contrast agent be used to monitor disease progression in muscular dystrophy?
Comment on
-
Dysferlin-deficient muscular dystrophy: gadofluorine M suitability at MR imaging in a mouse model.Radiology. 2009 Jan;250(1):87-94. doi: 10.1148/radiol.2501080180. Epub 2008 Nov 10. Radiology. 2009. PMID: 19001151
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical